vs
Side-by-side financial comparison of Strive, Inc. (ASST) and Longeveron Inc. (LGVN). Click either name above to swap in a different company.
Longeveron Inc. is the larger business by last-quarter revenue ($365.0K vs $255.0K, roughly 1.4× Strive, Inc.). Longeveron Inc. runs the higher net margin — -1491.5% vs -75406.7%, a 73915.2% gap on every dollar of revenue. On growth, Longeveron Inc. posted the faster year-over-year revenue change (-39.5% vs -74.1%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs -18.4%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
Longeveron Inc. is a clinical-stage biotechnology company specializing in regenerative medicine therapies for aging-related and life-threatening conditions. Its lead candidate targets geriatric frailty, Alzheimer's disease, and cardiovascular disorders, with core operations focused on the U.S. biopharmaceutical market.
ASST vs LGVN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $365.0K |
| Net Profit | $-192.3M | $-5.4M |
| Gross Margin | — | 70.4% |
| Operating Margin | -17288.6% | -1479.2% |
| Net Margin | -75406.7% | -1491.5% |
| Revenue YoY | -74.1% | -39.5% |
| Net Profit YoY | -2726.9% | -33.3% |
| EPS (diluted) | $-0.22 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $365.0K | ||
| Q3 25 | $255.0K | $137.0K | ||
| Q2 25 | $173.3K | $316.0K | ||
| Q1 25 | $170.7K | $381.0K | ||
| Q4 24 | $212.8K | $603.0K | ||
| Q3 24 | $984.0K | $773.0K | ||
| Q2 24 | $93.0K | $468.0K | ||
| Q1 24 | $124.8K | $548.0K |
| Q4 25 | — | $-5.4M | ||
| Q3 25 | $-192.3M | $-7.2M | ||
| Q2 25 | $-8.9M | $-5.0M | ||
| Q1 25 | $-3.7M | $-5.0M | ||
| Q4 24 | $-4.1M | $-4.1M | ||
| Q3 24 | $-6.8M | $-4.4M | ||
| Q2 24 | $-5.9M | $-3.4M | ||
| Q1 24 | $-4.8M | $-4.1M |
| Q4 25 | — | 70.4% | ||
| Q3 25 | — | 91.2% | ||
| Q2 25 | — | 46.2% | ||
| Q1 25 | — | 72.2% | ||
| Q4 24 | — | 87.7% | ||
| Q3 24 | — | 88.2% | ||
| Q2 24 | — | 73.5% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | -1479.2% | ||
| Q3 25 | -17288.6% | -5335.8% | ||
| Q2 25 | -1553.9% | -1707.9% | ||
| Q1 25 | -970.5% | -1359.8% | ||
| Q4 24 | -5889.5% | -710.3% | ||
| Q3 24 | -712.4% | -601.4% | ||
| Q2 24 | -1857.2% | -747.9% | ||
| Q1 24 | -1110.9% | -746.4% |
| Q4 25 | — | -1491.5% | ||
| Q3 25 | -75406.7% | -5270.8% | ||
| Q2 25 | -5122.4% | -1591.1% | ||
| Q1 25 | -2195.6% | -1315.2% | ||
| Q4 24 | -1935.5% | -677.1% | ||
| Q3 24 | -691.3% | -571.7% | ||
| Q2 24 | -6313.1% | -729.3% | ||
| Q1 24 | -3837.7% | -740.5% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | $-0.22 | $-0.39 | ||
| Q2 25 | $-0.17 | $-0.33 | ||
| Q1 25 | $-0.13 | $-0.34 | ||
| Q4 24 | $-5.62 | $1.16 | ||
| Q3 24 | $-3.06 | $-0.34 | ||
| Q2 24 | $-0.58 | $-1.83 | ||
| Q1 24 | $-0.49 | $-1.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.4M | $5.7M |
| Total Assets | $792.6M | $10.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.7M | ||
| Q3 25 | $109.1M | $9.2M | ||
| Q2 25 | $2.5M | $10.3M | ||
| Q1 25 | $4.2M | $14.3M | ||
| Q4 24 | $6.2M | $19.2M | ||
| Q3 24 | $2.1M | $22.8M | ||
| Q2 24 | $1.9M | $12.4M | ||
| Q1 24 | $1.9M | $2.3M |
| Q4 25 | — | $5.7M | ||
| Q3 25 | $779.4M | $10.0M | ||
| Q2 25 | $10.7M | $12.7M | ||
| Q1 25 | $19.6M | $17.2M | ||
| Q4 24 | $23.3M | $21.9M | ||
| Q3 24 | $27.5M | $25.6M | ||
| Q2 24 | $5.4M | $14.9M | ||
| Q1 24 | $11.3M | $3.0M |
| Q4 25 | — | $10.3M | ||
| Q3 25 | $792.6M | $15.6M | ||
| Q2 25 | $3.3M | $16.7M | ||
| Q1 25 | $5.0M | $20.8M | ||
| Q4 24 | $28.2M | $25.6M | ||
| Q3 24 | $2.6M | $29.9M | ||
| Q2 24 | $2.4M | $19.4M | ||
| Q1 24 | $2.1M | $9.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-5.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | $-14.0M | $-5.1M | ||
| Q2 25 | $-1.7M | $-3.6M | ||
| Q1 25 | $-1.6M | $-4.7M | ||
| Q4 24 | $-21.6M | $-3.4M | ||
| Q3 24 | $-13.2M | $-2.8M | ||
| Q2 24 | $-1.3M | $-4.6M | ||
| Q1 24 | $-1.0M | $-3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-4.7M | ||
| Q4 24 | $-21.6M | $-3.4M | ||
| Q3 24 | $-13.4M | $-3.3M | ||
| Q2 24 | $-1.3M | $-4.8M | ||
| Q1 24 | $-1.1M | $-3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | -3731.4% | ||
| Q2 25 | — | -1189.2% | ||
| Q1 25 | — | -1239.9% | ||
| Q4 24 | -10161.2% | -561.5% | ||
| Q3 24 | -1360.3% | -423.4% | ||
| Q2 24 | -1379.4% | -1017.5% | ||
| Q1 24 | -844.7% | -566.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.0% | 41.6% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | 11.3% | 2.2% | ||
| Q3 24 | 18.8% | 55.6% | ||
| Q2 24 | 3.1% | 41.9% | ||
| Q1 24 | 9.5% | 2.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
